Cargando…
Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
BACKGROUND: Colorectal cancer is the third most common cancer and a major cause of morbidity and mortality worldwide. Adjuvant chemotherapy is considered the standard of care in patients with UICC stage III colon cancer after R0 resection. Adjuvant therapy was not shown to be beneficial in patients...
Autores principales: | Teufel, Andreas, Gerken, Michael, Hartl, Janine, Itzel, Timo, Fichtner-Feigl, Stefan, Stroszczynski, Christian, Schlitt, Hans Jürgen, Hofstädter, Ferdinand, Klinkhammer-Schalke, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451874/ https://www.ncbi.nlm.nih.gov/pubmed/25985893 http://dx.doi.org/10.1186/s12885-015-1404-9 |
Ejemplares similares
-
Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects
por: Munker, Stefan, et al.
Publicado: (2018) -
Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis
por: Glockzin, Gabriel, et al.
Publicado: (2014) -
Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients
por: Taubenhansl, Clara, et al.
Publicado: (2019) -
Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma
por: Hackl, Christina, et al.
Publicado: (2014) -
Long-term oncologic outcomes after laparoscopic vs. open colon cancer resection: a high-quality population-based analysis in a Southern German district
por: Völkel, Vinzenz, et al.
Publicado: (2018)